Related references
Note: Only part of the references are listed.The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer
Rabia A. Gilani et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer
Andrew J. Armstrong et al.
EUROPEAN UROLOGY (2012)
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
Linda Sofie Lindstrom et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci et al.
LANCET ONCOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell et al.
PLOS ONE (2012)
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2011)
Acquired endocrine resistance in breast cancer: implications for tumour metastasis
Edd Hayes et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Circulating Tumor Cells: Not All Detected Cells Are Bad and Not All Bad Cells Are Detected
Max S. Wicha et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Novel Platform for Detection of CK+ and CK- CTCs
Chad V. Pecot et al.
CANCER DISCOVERY (2011)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Re: Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
Daniel F. Hayes et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Heterogeneity of breast cancer metastases: Comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases
Julie M. Wu et al.
CLINICAL CANCER RESEARCH (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
Hans Neubauer et al.
BREAST CANCER RESEARCH (2008)
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Tanja Fehm et al.
BREAST CANCER RESEARCH (2008)
Reversal of the estrogen receptor-negative phenotype in breast cancer and restoration of antiestrogen response
Jill Bayliss et al.
CLINICAL CANCER RESEARCH (2007)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
JM Gee et al.
ENDOCRINE-RELATED CANCER (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome
G Wiedswang et al.
CLINICAL CANCER RESEARCH (2004)
Circulating tumor cells in patients with breast cancer dormancy
SD Meng et al.
CLINICAL CANCER RESEARCH (2004)
Drug therapy: Aromatase inhibitors in breast cancer
IE Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes
F Cardoso et al.
ANNALS OF ONCOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Association of angiogenesis in lymph node metastases with outcome of breast cancer
AJ Guidi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
